Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats
- PMID: 3680316
- DOI: 10.1002/jbm.820211106
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats
Abstract
A copolymer of N-(2-hydroxypropyl) methacrylamide (HPMA) and N-methacryloyltyrosinamide was prepared and fractionated using Sepharose 4B/6B (1:1) chromatography to produce eight HPMA copolymer fractions of narrow polydispersity and mean molecular weight (Mw) ranging from 12 to 778 kD. These fractions were radioiodinated and injected intravenously, subcutaneously, and intraperitoneally into rats. Their bloodstream-concentration profiles were monitored and rates of excretion assessed. Following intravenous administration the circulating blood volume available to the copolymers was not molecular-weight-dependent. A molecular-weight threshold limiting glomerular filtration was identified at approximately 45 kD, and preparations greater than this threshold were lost from the bloodstream only slowly by extravasation. Molecular weight did not influence the movement of copolymers from the peritoneal compartment to the bloodstream after intraperitoneal injection. The transfer rates observed could be accounted for by bulk phase lymphatic drainage alone, no transcapillary routes being implicated. Following subcutaneous administration the largest HPMA copolymer fraction (Mw = 778 kD, diameter approximately 30 nm) showed increased retention at the site of the injection, approximately 20% of the dose remaining there after 21 days. This could result from physical restriction of movement or from internalization into local phagocytic cells. The smaller copolymer fractions moved readily into the bloodstream whence they were either lost in the urine or they gradually penetrated into other tissues and organs. Long-term (21 days) body distribution of copolymers following both intraperitoneal and subcutaneous administration showed size-dependent accumulation in organs of the reticuloendothelial system.
Similar articles
-
Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.PDA J Pharm Sci Technol. 2001 May-Jun;55(3):191-201. PDA J Pharm Sci Technol. 2001. PMID: 11417110
-
Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.J Drug Target. 1996;3(5):375-83. doi: 10.3109/10611869608996828. J Drug Target. 1996. PMID: 8866656
-
Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.Adv Drug Deliv Rev. 2010 Feb 17;62(2):246-57. doi: 10.1016/j.addr.2009.12.007. Epub 2010 Jan 7. Adv Drug Deliv Rev. 2010. PMID: 20060431 Review.
-
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.Br J Cancer. 1988 Feb;57(2):147-56. doi: 10.1038/bjc.1988.31. Br J Cancer. 1988. PMID: 3358905 Free PMC article.
-
Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.Neoplasia. 2006 Oct;8(10):788-95. doi: 10.1593/neo.06436. Neoplasia. 2006. PMID: 17032495 Free PMC article.
Cited by
-
Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.Mol Pharm. 2010 Aug 2;7(4):1041-9. doi: 10.1021/mp100132h. Mol Pharm. 2010. PMID: 20557133 Free PMC article.
-
Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.Pharm Res. 2002 Feb;19(2):115-23. doi: 10.1023/a:1014216712820. Pharm Res. 2002. PMID: 11883637
-
HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer.Pharm Res. 2010 Dec;27(12):2683-93. doi: 10.1007/s11095-010-0267-7. Epub 2010 Sep 16. Pharm Res. 2010. PMID: 20845065
-
Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells.Eur J Pharm Biopharm. 2014 May;87(1):187-96. doi: 10.1016/j.ejpb.2013.11.008. Epub 2013 Dec 4. Eur J Pharm Biopharm. 2014. PMID: 24316339 Free PMC article.
-
Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers.Adv Healthc Mater. 2022 Nov;11(22):e2201344. doi: 10.1002/adhm.202201344. Epub 2022 Nov 7. Adv Healthc Mater. 2022. PMID: 36153823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources